The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 03, 2020

Filed:

May. 07, 2010
Applicants:

Valerie Petit, Palezieux, CH;

Clara Garcia-rodenas, Forel, CH;

Monique Julita, Prilly, CH;

Guenolee Prioult, Lausanne, CH;

Annick Mercenier, Bussigny, CH;

Sophie Nutten, Lausanne, CH;

Inventors:

Valerie Petit, Palezieux, CH;

Clara Garcia-Rodenas, Forel, CH;

Monique Julita, Prilly, CH;

Guenolee Prioult, Lausanne, CH;

Annick Mercenier, Bussigny, CH;

Sophie Nutten, Lausanne, CH;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/74 (2015.01); A61K 35/745 (2015.01); A61K 35/747 (2015.01); A23L 33/00 (2016.01); A23L 33/135 (2016.01); A23K 10/18 (2016.01); A61K 35/744 (2015.01); C12N 1/20 (2006.01); C12N 1/00 (2006.01); C12N 1/36 (2006.01);
U.S. Cl.
CPC ...
A61K 35/745 (2013.01); A23K 10/18 (2016.05); A23L 33/135 (2016.08); A23L 33/40 (2016.08); A61K 35/74 (2013.01); A61K 35/744 (2013.01); A61K 35/747 (2013.01); C12N 1/005 (2013.01); C12N 1/20 (2013.01); C12N 1/36 (2013.01); A23V 2002/00 (2013.01); A23Y 2220/03 (2013.01); A23Y 2220/15 (2013.01); A23Y 2220/17 (2013.01); A23Y 2220/43 (2013.01); A23Y 2220/63 (2013.01); A23Y 2220/71 (2013.01); A23Y 2220/73 (2013.01); A23Y 2240/41 (2013.01); A23Y 2240/75 (2013.01); A23Y 2300/29 (2013.01); A23Y 2300/49 (2013.01); A23Y 2300/55 (2013.01); Y02A 50/473 (2018.01);
Abstract

The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of non-replicatingLa1 NCC533 (deposit number CNCM I-1225) for use in the treatment or prevention of disorders related to the immune system including infections.


Find Patent Forward Citations

Loading…